Cargando…
Current State of Fluid Lipid Biomarkers for Personalized Diagnostics and Therapeutics in Schizophrenia Spectrum Disorders and Related Psychoses: A Narrative Review
Schizophrenia spectrum disorders (SSD) are traditionally diagnosed and categorized through clinical assessment, owing to their complex heterogeneity and an insufficient understanding of their underlying pathology. However, disease progression and accurate clinical diagnosis become problematic when d...
Autores principales: | Couttas, Timothy A., Jieu, Beverly, Rohleder, Cathrin, Leweke, F. Markus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9197191/ https://www.ncbi.nlm.nih.gov/pubmed/35711577 http://dx.doi.org/10.3389/fpsyt.2022.885904 |
Ejemplares similares
-
Cannabidiol enhances cerebral glucose utilization and ameliorates psychopathology and cognition: A case report in a clinically high-risk mental state
por: Koethe, Dagmar, et al.
Publicado: (2023) -
Neural Autoantibodies in Cerebrospinal Fluid and Serum in Clinical High Risk for Psychosis, First-Episode Psychosis, and Healthy Volunteers
por: Bien, Christian G., et al.
Publicado: (2021) -
Case Report: Severe Adolescent Major Depressive Syndrome Turns Out to Be an Unusual Case of Anti-NMDA Receptor Encephalitis
por: Moldavski, Alexander, et al.
Publicado: (2021) -
Problematic Drug Use Among Outpatients With Schizophrenia and Related Psychoses
por: Chang, Sherilyn, et al.
Publicado: (2021) -
Simultaneous Assessment of Serum Levels and Pharmacologic Effects of Cannabinoids on Endocannabinoids and N-Acylethanolamines by Liquid Chromatography–Tandem Mass Spectrometry
por: Couttas, Timothy A., et al.
Publicado: (2023)